EA201891690A1 - Агонист fxr, представляющий собой производное стероидов - Google Patents

Агонист fxr, представляющий собой производное стероидов

Info

Publication number
EA201891690A1
EA201891690A1 EA201891690A EA201891690A EA201891690A1 EA 201891690 A1 EA201891690 A1 EA 201891690A1 EA 201891690 A EA201891690 A EA 201891690A EA 201891690 A EA201891690 A EA 201891690A EA 201891690 A1 EA201891690 A1 EA 201891690A1
Authority
EA
Eurasian Patent Office
Prior art keywords
presenting
fxr agonist
steroid derivative
relates
fxr
Prior art date
Application number
EA201891690A
Other languages
English (en)
Other versions
EA038580B1 (ru
EA038580B9 (ru
Inventor
Хайин Хэ
Хуалин Сяо
Пэн ЛИ
Чуньянь Ду
Чжи Ло
Шухуэй Чэнь
Original Assignee
Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд. filed Critical Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд.
Priority claimed from PCT/CN2017/072567 external-priority patent/WO2017129125A1/zh
Publication of EA201891690A1 publication Critical patent/EA201891690A1/ru
Publication of EA038580B1 publication Critical patent/EA038580B1/ru
Publication of EA038580B9 publication Critical patent/EA038580B9/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Abstract

Изобретение относится к соединению, представленному посредством формулы (I), его таутомеру или его фармацевтически приемлемой соли, а также относится к путям их применения в получении независимых средств для лечения заболеваний, связанных с FXR.
EA201891690A 2016-05-18 2017-01-25 Агонист fxr, представляющий собой производное стероидов EA038580B9 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610331759 2016-05-18
PCT/CN2017/072567 WO2017129125A1 (zh) 2016-01-28 2017-01-25 甾体类衍生物fxr激动剂

Publications (3)

Publication Number Publication Date
EA201891690A1 true EA201891690A1 (ru) 2019-04-30
EA038580B1 EA038580B1 (ru) 2021-09-17
EA038580B9 EA038580B9 (ru) 2021-10-05

Family

ID=66436959

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201891690A EA038580B9 (ru) 2016-05-18 2017-01-25 Агонист fxr, представляющий собой производное стероидов

Country Status (1)

Country Link
EA (1) EA038580B9 (ru)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48286E1 (en) * 2001-03-12 2020-10-27 Intercept Pharmaceuticals, Inc. Steroids as agonists for FXR
EP1568706A1 (en) * 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
WO2016086134A1 (en) * 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
US10208081B2 (en) * 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
EP3277286B1 (en) * 2015-03-31 2021-04-21 Enanta Pharmaceuticals, Inc. Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
CN106083978A (zh) * 2015-04-28 2016-11-09 上海迪诺医药科技有限公司 磺酰基氨基羰基衍生物、其药物组合物及应用
US20180148470A1 (en) * 2015-04-28 2018-05-31 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Cholic acid derivative, and preparation method and medical use thereof

Also Published As

Publication number Publication date
EA038580B1 (ru) 2021-09-17
EA038580B9 (ru) 2021-10-05

Similar Documents

Publication Publication Date Title
PH12018550120A1 (en) Steroid derivative fxr agonist
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
CY1123595T1 (el) Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5
EA201991693A1 (ru) Производное пиридина в качестве ингибитора ask1 и способ его получения и применения
PH12018500040A1 (en) Indazole and azaindazole compounds as irak-4 inhibitors
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
MY192717A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
EA201790078A1 (ru) Ингибиторы mnk и связанные с ними способы
EA202090291A2 (ru) Производные бипиразола в качестве ингибиторов jak
EA201591612A1 (ru) ПРИМЕНЕНИЕ ПИРАЗОЛПИРИМИДИНОВЫХ ПРОИЗВОДНЫХ ДЛЯ ЛЕЧЕНИЯ НАРУШЕНИЙ, СВЯЗАННЫХ С PI3Kδ
TR201901312T4 (tr) Mcl-1 proteinini inhibe eden tetrahidronaftalen türevleri.
EA201692316A1 (ru) Производные холана для применения при лечении и/или профилактике fxr и tgr5/gpbar1-опосредованных заболеваний
EA201691803A1 (ru) Ингибиторы калликреина плазмы человека
BR112016015236A2 (pt) inibidores de serina/treonina quinase
PH12016502353A1 (en) Pharmaceutical composition
MX2018004664A (es) Antagonistas de ep4.
MX2015015168A (es) Derivados heterociclicos y sus usos.
PL410665A1 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
CY1124251T1 (el) Παραγωγα καρβοξαμιδιου
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
CO2017000011A2 (es) Derivados de quinolizinona como inhibidores de pi3k
MX2018008307A (es) Derivado de ascoclorina y uso del mismo como activador de proteina cinasa activada por adenosin monofosfato (ampk).
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
EA201791099A1 (ru) Хинолин карбоксамиды для применения в лечении лейкоза

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent